SEVERE WX : Air Stagnation Advisory View Alerts

Breast cancer risk linked to hormone therapy can persist for years, study says

Certain hormone replacement therapies have long been tied to an...

Posted: Aug 30, 2019 7:29 AM

Certain hormone replacement therapies have long been tied to an increased risk of breast cancer. Now, new research suggests that in some cases, that risk can persist for more than a decade.

The research, published in the journal The Lancet on Thursday, found that risks increased steadily the longer the hormone replacement therapy was used, and were greater for estrogen-progestogen hormone therapies than for estrogen-only hormone therapy. Every type of hormone replacement therapy, except for vaginal estrogens, was associated with excess breast cancer risks.

The menopausal transition most often begins between ages 45 and 55, causing symptoms to appear due to changes in the body's production of the sex hormones estrogen and progesterone. Sometimes women take hormone replacement therapy, also called HRT or menopausal hormone therapy, to help relieve symptoms of menopause, such as hot flashes, night sweats, pain during sex and vaginal dryness. Those symptoms can be mild in some women but can impact the wellbeing of others. The hormones most commonly used to treat symptoms of menopause are estrogen and progesterone.

'Excess risk persisted for more than 10 years'

The new research was based on an analysis of data from 58 previously published studies on hormone replacement therapy, which included more than 100,000 postmenopausal women with invasive breast cancer.

The researchers found that for women of average weight in Western countries, five years of using estrogen plus a daily progestogen hormone therapy, starting at age 50, was associated with an increased risk of breast cancer up to age 70.

Specifically, the research suggests that the estimated incidence of breast cancer at ages 50 to 69 was tied to an increased risk -- from 6.3% of women who never used hormone replacement therapy to 8.3% of those who used the therapy daily for five years.

That's an increase of about one extra cancer case in every 50 users of the therapy, according to the research.

Similarly, five years of using estrogen plus intermittent progestogen hormone therapy was tied to an increased risk, from 6.3% to 7.7%, representing an increase of one extra cancer case in every 70 users of the therapy, the research suggests.

The research also suggests that five years of using an estrogen-only therapy was tied to an increased risk, from 6.3% to 6.8%, which would be an increase of one extra cancer case in every 200 users of the therapy.

Even if therapy is stopped at some point, "some excess risk persisted for more than 10 years," the researchers wrote.

The new research showed just an association between hormone replacement therapy and breast cancer -- not a causal relationship. More research is needed to determine whether hormone replacement therapy actually caused increases in breast cancer incidence.

If the associations in the new research are largely causal, the data suggests that menopausal hormone therapy used in Western countries may have caused about 1 million breast cancers out of the total 20 million that have occurred worldwide since 1990.

Weighing the risks and benefits

The findings came as no surprise to Dr. Otis Brawley, Bloomberg distinguished professor of oncology and epidemiology at Johns Hopkins University in Baltimore, who was not involved in the new research.

"For 18 years now I have been trying to convince women that they don't want to start postmenopausal estrogens, and I've been encouraging women who have hot flashes to try to resolve those hot flashes through other medical means," Brawley said.

"Now there's some women who have hot flashes that are so significant that giving them estrogen actually is worth the risk," he said. "Virtually everything we do in medicine has a risk and a benefit to it, and when the benefit starts getting to be clearly higher than the risk then perhaps you ought to do it, but when the benefit is not clearly higher than the risk, I try to avoid using it."

In general, the US Food and Drug Administration says not to take hormone therapy if you have problems with vaginal bleeding; have or had a history of certain cancers; have or had a blood clot, stroke or heart attack; or have a bleeding disorder, liver disease or allergic reactions to hormone medicine.

For women who are already taking a hormone replacement therapy and might have some concerns, Brawley said to talk to your doctor.

The new research should help both women and their doctors in deciding whether or when to start hormone therapy and which preparation to take -- estrogen and progestogen combined or estrogen alone, Dr. Janice Rymer, gynecologist and vice president of the Royal College of Obstetricians and Gynaecologists in the United Kingdom, said in a written statement distributed by the Science Media Centre.

"Women must be informed of the small increase in risk of breast cancer so they can weigh these up against the benefits that they may have from taking HRT," Rymer said in the statement. She was not involved in the research.

"These findings should not put women off taking HRT if the benefits -- such as protection of bones and decrease in cardiovascular risk -- outweigh the risks," she said. "To put the risk into context, a woman has greater risk of developing breast cancer if she is overweight or obese compared to taking HRT."

'We would urge patients not to panic'

The Royal College of General Practitioners in the United Kingdom urged women not to panic as a result of the new research.

"The link between HRT and an increased risk of breast cancer has been known for some time. But it is a complex relationship," Martin Marshall, vice chair of the Royal College of General Practitioners, said in a written statement in response to the research.

"There is still a lot of evidence to suggest that HRT is safe and effective, and current clinical guidelines recommend it as an appropriate treatment for some women going through menopause. Nevertheless, it is important that clinical guidelines are evidence-based, and that this study is taken into account as clinical guidelines are updated and developed," he said. "We would urge patients not to panic as a result of this research, and to continue taking HRT as it has been prescribed to them -- and we would urge prescribers to do so as normal, until clinical guidelines recommend otherwise."

Oregon Coronavirus Cases

Data is updated nightly.

Cases: 68503

Reported Deaths: 867
CountyCasesDeaths
Multnomah15561230
Washington940198
Marion8650135
Clackamas568777
Umatilla421248
Lane405040
Jackson357925
Malheur234942
Deschutes207414
Yamhill161516
Linn131019
Polk114015
Douglas88217
Jefferson79811
Union7463
Klamath7454
Benton7447
Morrow6357
Lincoln60014
Wasco49719
Josephine4824
Columbia4573
Coos4061
Hood River3751
Clatsop3450
Baker2703
Crook2086
Grant1301
Curry1202
Tillamook1150
Lake1131
Harney901
Wallowa703
Sherman230
Gilliam210
Wheeler30
Unassigned00

California Coronavirus Cases

Data is updated nightly.

Cases: 1160940

Reported Deaths: 18968
CountyCasesDeaths
Los Angeles3783237543
San Bernardino884531129
Riverside836851434
San Diego75305988
Orange731521559
Kern39721447
Fresno37021477
Sacramento35143557
Santa Clara32049470
Alameda28225502
San Joaquin25318504
Contra Costa23146258
Stanislaus21145422
Tulare20352305
Ventura18637175
Imperial15725356
San Francisco14874160
Monterey14354116
San Mateo13707170
Sonoma11712157
Merced11460179
Santa Barbara11166135
Kings1035987
Solano1003681
Marin7621129
Placer622468
Madera604785
San Luis Obispo588535
Shasta460147
Yolo447674
Santa Cruz413228
Butte381259
Sutter305715
Napa290417
El Dorado20914
Yuba194810
San Benito178416
Lassen17153
Tehama156525
Mendocino146822
Nevada11639
Glenn8837
Lake87719
Tuolumne8738
Humboldt8199
Colusa6826
Siskiyou5822
Mono5093
Amador47016
Calaveras46622
Del Norte2981
Inyo28316
Plumas1920
Trinity1360
Mariposa1242
Modoc1190
Alpine470
Sierra190
Unassigned00
Medford
Clear
35° wxIcon
Hi: 51° Lo: 29°
Feels Like: 35°
Brookings
Clear
43° wxIcon
Hi: 57° Lo: 40°
Feels Like: 43°
Crater Lake
Clear
21° wxIcon
Hi: 43° Lo: 19°
Feels Like: °
Grants Pass
Overcast
32° wxIcon
Hi: 51° Lo: 29°
Feels Like: 32°
Klamath Falls
Clear
21° wxIcon
Hi: 42° Lo: 17°
Feels Like: °
Cold & foggy mornings, air quality concerns
KDRV Radar
KDRV Fire Danger
KDRV Weather Cam

Community Events